Global Leadless Pacemakers Market Size, Share & Trends Analysis Report by Pacing Chamber (Single Chamber, Dual Chamber), by End Use (Inpatient Facilities, Outpatient Facilities), and Regional Forecasts 2022-2032

Description

The global leadless pacemakers market size was valued at approximately USD 624.38 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 13.6% from 2022 to 2032. Leadless pacemakers represent a groundbreaking advancement in the field of cardiology, providing significant advantages over traditional pacemakers, including reduced infection risks, elimination of lead-related complications, and a minimally invasive implantation process. These features have bolstered their adoption for treating conditions such as bradycardia and atrial fibrillation.

The market's growth is being driven by the rising prevalence of cardiovascular diseases and an aging global population. According to the WHO, the number of individuals aged 60 and above is expected to increase from 1.4 billion in 2030 to nearly 2.1 billion by 2050, creating a substantial patient pool for cardiac care solutions. In addition, advancements in technology, such as the introduction of dual-chamber leadless pacemakers like Abbott's AVEIR DR and Medtronic's Micra AV2, are significantly boosting the market. These devices offer advanced functionalities, including synchronized pacing and improved hemodynamic performance, making them a preferred choice among healthcare professionals.

The demand for leadless pacemakers is further fueled by the rising incidence of arrhythmias, with atrial fibrillation being one of the most common types. According to the CDC, the prevalence of atrial fibrillation in the U.S. alone is projected to reach 12.1 million by 2030. Furthermore, favorable regulatory approvals, increasing adoption in pediatric and elderly care, and the rising prevalence of diabetes and obesity are accelerating market expansion. For instance, in 2024, Abbott secured CE Mark approval for its leadless dual-chamber pacemakers, expanding their availability across Europe.

North America emerged as the largest regional market in 2024, driven by advanced healthcare infrastructure, high healthcare spending, and the prevalence of cardiovascular diseases. Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth rate, fueled by rising healthcare investments, an increasing burden of cardiovascular disorders, and growing awareness about advanced cardiac care solutions.

Major market players included in this report are:

Medtronic
Abbott
Boston Scientific Corporation
EBR Systems, Inc.
MicroPort Scientific Corporation

The detailed segments and sub-segment of the market are explained below:

By Pacing Chamber:

Single Chamber
Dual Chamber

By End Use:

Inpatient Facilities
Outpatient Facilities

By Region:

North America:

U.S.
Canada
Mexico

Europe:

UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway

Asia Pacific:

China
Japan
India
South Korea
Australia
Thailand

Latin America:

Brazil
Argentina

Middle East & Africa:

South Africa
Saudi Arabia
UAE
Kuwait

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of geographical landscapes with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approaches.
Analysis of the competitive structure of the market.
Demand-side and supply-side analysis of the market.

Chapter 1. Global Leadless Pacemakers Market Executive Summary

1.1. Global Leadless Pacemakers Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Pacing Chamber
- 1.3.2. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Leadless Pacemakers Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Leadless Pacemakers Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing prevalence of cardiovascular diseases
- 3.1.2. Technological advancements in leadless pacemakers
- 3.1.3. Rising geriatric population
3.2. Market Challenges
- 3.2.1. High cost of leadless pacemakers
- 3.2.2. Regulatory complexities
3.3. Market Opportunities
- 3.3.1. Expanding adoption in emerging economies
- 3.3.2. Innovations in dual-chamber pacing technologies
- 3.3.3. Increasing focus on outpatient care solutions

Chapter 4. Global Leadless Pacemakers Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Leadless Pacemakers Market Size & Forecasts by Pacing Chamber (2022-2032)

5.1. Segment Dashboard
5.2. Global Leadless Pacemakers Market: Pacing Chamber Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Single Chamber
- 5.2.2. Dual Chamber

Chapter 6. Global Leadless Pacemakers Market Size & Forecasts by End Use (2022-2032)

6.1. Segment Dashboard
6.2. Global Leadless Pacemakers Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Inpatient Facilities
- 6.2.2. Outpatient Facilities

Chapter 7. Global Leadless Pacemakers Market Size & Forecasts by Region (2022-2032)

7.1. North America Leadless Pacemakers Market
- 7.1.1. U.S. Leadless Pacemakers Market
  - 7.1.1.1. Pacing Chamber breakdown size & forecasts, 2022-2032
  - 7.1.1.2. End Use breakdown size & forecasts, 2022-2032
- 7.1.2. Canada Leadless Pacemakers Market
- 7.1.3. Mexico Leadless Pacemakers Market
7.2. Europe Leadless Pacemakers Market
- 7.2.1. UK Leadless Pacemakers Market
- 7.2.2. Germany Leadless Pacemakers Market
- 7.2.3. France Leadless Pacemakers Market
- 7.2.4. Italy Leadless Pacemakers Market
- 7.2.5. Spain Leadless Pacemakers Market
- 7.2.6. Denmark Leadless Pacemakers Market
- 7.2.7. Sweden Leadless Pacemakers Market
- 7.2.8. Norway Leadless Pacemakers Market
7.3. Asia-Pacific Leadless Pacemakers Market
- 7.3.1. China Leadless Pacemakers Market
- 7.3.2. Japan Leadless Pacemakers Market
- 7.3.3. India Leadless Pacemakers Market
- 7.3.4. South Korea Leadless Pacemakers Market
- 7.3.5. Australia Leadless Pacemakers Market
- 7.3.6. Thailand Leadless Pacemakers Market
7.4. Latin America Leadless Pacemakers Market
- 7.4.1. Brazil Leadless Pacemakers Market
- 7.4.2. Argentina Leadless Pacemakers Market
7.5. Middle East & Africa Leadless Pacemakers Market
- 7.5.1. South Africa Leadless Pacemakers Market
- 7.5.2. Saudi Arabia Leadless Pacemakers Market
- 7.5.3. UAE Leadless Pacemakers Market
- 7.5.4. Kuwait Leadless Pacemakers Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Medtronic
- 8.1.2. Abbott
- 8.1.3. Boston Scientific Corporation
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Medtronic
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. Abbott
- 8.3.3. Boston Scientific Corporation
- 8.3.4. MicroPort Scientific Corporation
- 8.3.5. EBR Systems, Inc.

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes